Cancer Metabolism Based Therapeutics Market – Cancer metabolism targeted therapies offer significant opportunity for the pharmaceutical companies
https://truthdailymirror.com/cancer-metabolism-based-therapeutics-market-cancer-metabolism-targeted-therapies-offer-significant-opportunity-for-the-pharmaceutical-companies/817/
 

According to the study published in the Journal of Cancer Biology and Therapy, 2013, the controversial discovery of the 20th century by Otto Warburg led to study of metabolic activity in cancerous tissue, which increases the amount of production of lactate from glucose by tenfold under aerobic condition. This has revealed that heterogeneity is developed at cellular level leading to proliferation of cancerous cells due to increased metabolism rate. Cancer metabolism is based on the principle of cancer cells, which alter the metabolism of glucose and glutamine for the synthesis of lipids, nucleotides, fatty acids, and proteins that helps to proliferate cancer cells. It results in inhibition of various metabolic pathways, such as the citric acid cycle, glucose, mitochondrial respiration, and glutamine utilization. Limited options of cancer metabolism targeting therapies are expected provide potential opportunities for development of novel cancer metabolism-based therapeutics in the near future.

Global Cancer Metabolism Based Therapeutics Market Taxonomy

 

On the basis of drug and indication, cancer metabolism-based therapeutics market segmented into two categories

By Drug –

  • CPI-613
  • Enasidenib

By Indication –

  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Metastatic Renal Cell Carcinoma
  • Melanoma
  • Others